Cited by 121Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsAdipose Tissue and Metabolism

Intracellular Defects in Glucose Metabolism in Obese Patients With NIDDM

Kelley, David E, Mokan, Marian, Mandarino, Lawrence J·1992·Diabetes

Abstract

Skeletal muscle insulin resistance in obese patients with non-insulin-dependent diabetes mellitus (NIDDM) is characterized by decreased glucose uptake. Although reduced glycogen synthesis is thought to be the predominant cause for this deficit, studies supporting this notion often have been conducted at supraphysiological insulin concentrations in which glucose storage is the overwhelming pathway of glucose disposal. However, at lower, more physiological insulin concentrations, decreased muscle glucose oxidation could play a significant role. This study was undertaken to determine whether, under euglycemic conditions, insulin resistance for leg muscle glucose uptake in NIDDM patients is due primarily to decreased glucose storage or to oxidation. The leg balance technique and leg indirect calorimetry were used under steady-state euglycemic conditions to estimate muscle glucose uptake, storage, and oxidation in eight moderately obese NIDDM patients and eight matched-control subjects. Leg muscle biopsies also were performed to determine whether alterations in muscle pyruvate dehydrogenase or glycogen synthase activities could explain defects in glucose oxidation or storage. At insulin concentrations of ∼ 500–600 pM, leg glucose uptake, oxidation, and storage in the NIDDM group (2.03 ± 0.42, 1.00 ± 0.13, 0.66 ± 0.36 μmol · min−1 · 100 ml−1) were significantly lower (P < 0.05) than rates in control subjects (5.14 ± 0.64, 1.92 ± 0.17, 2.80 ± 0.54). Pyruvate dehydrogenase and glycogen synthase activities were also decreased, consistent with the in vivo metabolic defects. The average deficit in leg glucose uptake in NIDDM was 3.11 ± 0.42 μmol · min−1 μ 100 ml−1. Of this deficit, 66% (2.14 ± 0.36 μmol min−1 · 100 ml−1) was due to decreased leg glucose storage and 33% (0.92 ± 0.13 μmol min−1 · 100 ml−1) to decreased leg glucose oxidation. Our findings confirm that decreased muscle glucose storage during hyperinsulinemia is the largest defect in glucose metabolism but also reveal a major defect in glucose oxidation. These studies reinforce the notion that muscle insulin resistance in obese NIDDM patients is characterized by a panoply of intracellular defects in glucose metabolism and insulin action.

Integrity signals

Registry

Crossref · 10.2337/diab.41.6.698

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In type 2 diabetic patients, insulin-stimulated PDH activity is decreased in human skeletal muscle.

    “In type 2 diabetic patients, insulin-stimulated PDH activity has been shown to be decreased in human skeletal muscle [231, 232].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [232]

Cited by

Sorted by citations

Authors
Kelley, D. E., Mokan, M., & Mandarino, L. J.
Affiliations
  • University of Pittsburgh (US)
  • Departments of Medicine, Ophthalmology, and Physiology, the Eye and Ear Institute of Pittsburgh; and the Department of Veterans Affairs Medical Center Pittsburgh, Pennsylvania
Venue
Diabetes
Published
1992-06-01
Volume
41
Issue
6
Pages
698-706
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2165756853
Cited by
121
References
0
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 3 · 2015: 8 · 2014: 5 · 2013: 1 · 2012: 1
FWCI
1.72
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • National Institutes of Health (5r01dk041075-03)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK41075)
  • National Center for Research Resources (M01-RR00056, M01RR000056)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
insulin resistance, type 2 diabetes, skeletal muscle glucose uptake, muscle glycogen synthesis, pyruvate dehydrogenase, glycogen synthase, obesity, hyperinsulinemia, glucose storage
MeSH terms
Analysis of Variance, Blood Glucose, Carbon Dioxide, Diabetes Mellitus, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Glucose, Glycogen Synthase, Glycolysis, Humans, Insulin, Insulin Resistance, Kinetics, Male, Middle Aged, Muscles, Obesity, Oxygen, Oxygen Consumption, Partial Pressure, Pyruvate Dehydrogenase Complex, Reference Values

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review